ATHE Latest Press Releases

-- October 9, 2026 --

Alterity Therapeutics to Present at the Canaccord Genuity Drug and Device Conference Globe Newswire 7:05 AM

-- October 5, 2026 --

Alterity Therapeutics Presents New Analyses of ATH434 Phase 2 Data in Multiple System Atrophy at the 2026 International Congress of Parkinson's Disease and Movement Disorders Globe Newswire 7:05 AM

-- September 3, 2026 --

Alterity Therapeutics to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026 Globe Newswire 7:05 AM

-- August 12, 2026 --

Alterity Therapeutics Announces Granting of New U.S. Composition of Matter Patent for ATH434 Globe Newswire 7:05 AM

-- August 6, 2026 --

Alterity Therapeutics to Present at the 46th Annual Canaccord Genuity Growth Conference Globe Newswire 7:25 AM

-- July 30, 2026 --

Alterity Therapeutics Releases Appendix 4C - Q4 FY26 Quarterly Cash Flow Report & Corporate Update Globe Newswire 7:25 AM

-- July 21, 2026 --

Alterity Therapeutics to Participate in the Virtual BTIG Biotechnology Conference 2026 Globe Newswire 7:25 AM

-- July 7, 2026 --

Alterity Therapeutics Receives FDA End-of-Phase 2 Meeting Minutes Confirming Registrational Pathway for ATH434 in Multiple System Atrophy Globe Newswire 7:05 AM

-- June 9, 2026 --

Alterity Therapeutics Achieves Alignment with U.S. FDA on Pivotal Phase 3 Program for ATH434 in Multiple System Atrophy Globe Newswire 7:05 AM

Market Data Delayed 15 Minutes